LORA VAVERKA: Open Payments
NPI 1124036744 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 60 payments from 26 companies in 2025. Trend: 2023 $30 · 2024 $1,670 · 2025 $1,435
Food & beverage: $1,270Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $177 |
| SOBI, INC | 3 | $147 |
| Incyte Corporation | 3 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| PUMA BIOTECHNOLOGY, INC. | 5 | $110 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Merck Sharp & Dohme LLC | 4 | $83 |
| Genentech USA, Inc. | 3 | $67 |
| PFIZER INC. | 3 | $58 |
| Eisai Inc. | 2 | $57 |
Products named: RYBREVANT, Doptelet, NERLYNX, KEYTRUDA, KISQALI, Lenvima, Xtandi, JAKAFI.
Industry payments across OK — which companies pay providers there.
